Paul Wang

Director, Cardiac Electrophysiology & Arrhythmia Service Professor of Medicine and of Bioengineering (by courtesy)
Stanford University
Stanford, CA

Dr. Wang is the Director of the Stanford Cardiac Arrhythmia Service.  Dr. Wang received his undergraduate degree at Harvard University and his medical degree at Columbia University in New York City. He received his medical residency at Columbia-Presbyterian Medical Center in New York City and completed his cardiovascular training at Brigham and Women’s Hospital, a major teaching institution of Harvard Medical School. He was Associate Director of Cardiac Electrophysiology Laboratory at Tufts-New England Medical Center in Boston for 14 years prior to coming to direct the Stanford Cardiac Arrhythmia Service 11 years ago. He has co-authored textbooks on implantable defibrillators, sudden cardiac death, cardiac resynchronization/ biventricular pacing therapy, and innovations in arrhythmia therapy. Dr. Wang participates on numerous national boards and panels in cardiac electrophysiology. He is a member and Chair of the American Heart Association Council on Clinical Cardiology ECG and Arrhythmias Committee and the past member of the American College of Cardiology Electrophysiology Committee. He was previously a member of the Cardiac Electrophysiology Board Certification Exam Writing Committee of the American Board of Internal Medicine. He was past Chair of the CME Compliance Subcommittee and Vice-Chair of the Education Committee of the Heart Rhythm Society.  He was an Associate Editor of the Heart Rhythm Journal. Dr. Wang is Co-Director of the Bioengineering Scholarly Concentration of the Stanford School of Medicine.   Dr. Wang directs the course Bioengineering 390, Introduction to Bioengineering Research.  Dr. Wang with Dr. Paul Yock organizes an annual meeting, “Stanford Biodesign New Arrhythmia Technologies Retreat”, focusing on new technological advances in arrhythmia management and diagnosis.

Dr. Wang's research studies centers on the development of innovative approaches to the treatment of arrhythmias, including catheter ablation, implantable devices, and diagnostic techniques.   Dr. Wang has invented a number of new arrhythmia technologies.  Dr. Wang is co-inventor of a cryoablation method and device that has been the basis of a cryoablation catheter which has been FDA approved (Cryocath, Inc. acquired by Medtronic, Inc.).  Dr. Wang’s contributions have led to development of a real-time correlation wave form analysis and T wave subtraction technique that has been incorporated into EP laboratory systems.  Dr. Wang is working on several novel approaches to treatment of arrhythmias using catheter and surgical ablation.  

Dr. Wang's clinical research interests include atrial fibrillation, ventricular tachycardia, catheter ablation, and implantable pacemakers and implantable defibrillators.